121 related articles for article (PubMed ID: 34313250)
1. Influence of nNav1.5 on MHC class I expression in breast cancer.
Murtadha AH; Azahar IIM; Sharudin NA; Che Has AT; Mokhtar NF
J Biosci; 2021; 46():. PubMed ID: 34313250
[TBL] [Abstract][Full Text] [Related]
2. Invasion and Metastasis Suppression by Anti-Neonatal Nav1.5 Antibodies in Breast Cancer.
Sharudin NA; Murtadha Noor Din AH; Azahar II; Mohd Azlan M; Yaacob NS; Sarmiento ME; Dominguez AA; Mokhtar NF
Asian Pac J Cancer Prev; 2022 Sep; 23(9):2953-2964. PubMed ID: 36172657
[TBL] [Abstract][Full Text] [Related]
3. nNav1.5 expression is associated with glutamate level in breast cancer cells.
Azahar II; Sharudin NA; Noor Din AHM; Che Has AT; Mohd Nafi SN; Jaafar H; Mokhtar NF
Biol Res; 2022 Apr; 55(1):18. PubMed ID: 35488278
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer invasiveness in vitro: Predominant contribution of neonatal Nav1.5 under normoxia and hypoxia.
Guzel RM; Ogmen K; Ilieva KM; Fraser SP; Djamgoz MBA
J Cell Physiol; 2019 May; 234(5):6582-6593. PubMed ID: 30341901
[TBL] [Abstract][Full Text] [Related]
5. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells.
Brackenbury WJ; Chioni AM; Diss JK; Djamgoz MB
Breast Cancer Res Treat; 2007 Jan; 101(2):149-60. PubMed ID: 16838113
[TBL] [Abstract][Full Text] [Related]
6. Discovery and evaluation of nNa
Dutta S; Lopez Charcas O; Tanner S; Gradek F; Driffort V; Roger S; Selander K; Velu SE; Brouillette W
Bioorg Med Chem; 2018 May; 26(9):2428-2436. PubMed ID: 29673714
[TBL] [Abstract][Full Text] [Related]
7. [Upregulation of MHC I Antigen Processing Machinery Gene Expression in Breast Cancer Cells by Trichostatin A].
Murtadha AH; Sharudin NA; Azahar IIM; Che Has AT; Mokhtar NF
Mol Biol (Mosk); 2023; 57(6):21-30. PubMed ID: 38062971
[TBL] [Abstract][Full Text] [Related]
8. Sigma-1 receptors modulate neonatal Na
Aydar E; Stratton D; Fraser SP; Djamgoz MB; Palmer C
Eur Biophys J; 2016 Oct; 45(7):671-683. PubMed ID: 27160185
[TBL] [Abstract][Full Text] [Related]
9. Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells.
Xing D; Wang J; Ou S; Wang Y; Qiu B; Ding D; Guo F; Gao Q
Oncol Rep; 2014 Jun; 31(6):2692-700. PubMed ID: 24756536
[TBL] [Abstract][Full Text] [Related]
10. Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancer.
Yamaci RF; Fraser SP; Battaloglu E; Kaya H; Erguler K; Foster CS; Djamgoz MBA
Pathol Res Pract; 2017 Aug; 213(8):900-907. PubMed ID: 28698102
[TBL] [Abstract][Full Text] [Related]
11. The role of REST and HDAC2 in epigenetic dysregulation of Nav1.5 and nNav1.5 expression in breast cancer.
Kamarulzaman NS; Dewadas HD; Leow CY; Yaacob NS; Mokhtar NF
Cancer Cell Int; 2017; 17():74. PubMed ID: 28785170
[TBL] [Abstract][Full Text] [Related]
12. Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives.
Rajaratinam H; Mokhtar NF; Asma-Abdullah N; Fuad WEM
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204811
[TBL] [Abstract][Full Text] [Related]
13. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.
Liu Y; Komohara Y; Domenick N; Ohno M; Ikeura M; Hamilton RL; Horbinski C; Wang X; Ferrone S; Okada H
Cancer Immunol Immunother; 2012 Jun; 61(6):789-801. PubMed ID: 22065046
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells.
Aktas CC; Zeybek ND; Piskin AK
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):680-6. PubMed ID: 26206582
[TBL] [Abstract][Full Text] [Related]
15. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase A and regulation of neonatal Nav1.5 expression in human breast cancer cells: activity-dependent positive feedback and cellular migration.
Chioni AM; Shao D; Grose R; Djamgoz MB
Int J Biochem Cell Biol; 2010 Feb; 42(2):346-58. PubMed ID: 19948241
[TBL] [Abstract][Full Text] [Related]
17. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
Elajnaf T; Baptista-Hon DT; Hales TG
Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
[TBL] [Abstract][Full Text] [Related]
19. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
[TBL] [Abstract][Full Text] [Related]
20. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
